Recruiting
Phase 3

CAR-T Long Term Follow Up (LTFU) Study

Sponsor:

Novartis Pharmaceuticals

Code:

NCT02445222

Conditions

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Previously treated CAR-T patients

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information